Inventor · disambiguated record
Paul Robbins
Also filed as: ROBBINS PAUL · ROBBINS PAUL B · ROBBINS PAUL BRIAN
9 granted patents·10 pending applications·52 citations·filing 2004–2023
86Inventor score
Files withPROLEXYS PHARMACEUTICALS INC7MEDIMMUNE LLC4MEDIMMUNE LTD4ARES TRADING SA1BECKLIN ROBERT R1
Top patents by PatentIndex Score
19 records- 0191US7615554B2Erastin and erastin binding proteins, and uses thereofPROLEXYS PHARMACEUTICALS INC·Filed 2006·Granted Nov 10, 2009·30 cites·23 claims
- 0285US10829557B2Anti-B7-H1 antibodies for treating tumorsMEDIMMUNE LTD·Filed 2019·Granted Nov 10, 2020·2 cites·9 claims
- 0385US10232040B2Anti-B7 H1 and anti-CTLA-4 antibodies for treating non-small cell lung cancerMEDIMMUNE LLC·Filed 2015·Granted Mar 19, 2019·6 cites·36 claims
- 0478US11446377B2Anti-B7-H1 and anti-CTLA-4 antibodies for treating non-small cell lung cancerMEDIMMUNE LLC·Filed 2019·Granted Sep 20, 2022·1 cites·13 claims
- 0576US10336823B2Anti-B7-H1 antibodies for treating tumorsMEDIMMUNE LTD·Filed 2014·Granted Jul 2, 2019·3 cites·18 claims
- 0674US8518959B2Quinoxaline derivatives as antitumor agentsBECKLIN ROBERT R·Filed 2006·Granted Aug 27, 2013·5 cites·17 claims
- 0771US2023115328A1Anti-B7-H1 and Anti-CTLA-4 Antibodies for Treating Non-Small Cell Lung CancerMEDIMMUNE LLC·Filed 2022·Application pending·0 cites
- 0869US11827706B2Anti-B7-H1 antibodies for treating tumorsMEDIMMUNE LTD·Filed 2020·Granted Nov 28, 2023·0 cites·20 claims
- 0969US7825227B2Method for purification of a protein complex and identification of its componentsPROLEXYS PHARMACEUTICALS INC·Filed 2004·Granted Nov 2, 2010·3 cites·14 claims
- 1069US2011123486A1Methods of treating multiple myeloma and resistant cancersPROLEXYS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1168US8575143B23-aryl-substituted quinazolones, and uses thereofQI LONGWU·Filed 2006·Granted Nov 5, 2013·2 cites·28 claims
- 1264US2014227221A1Methods of treating multiple myeloma and resistant cancersPROLEXYS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1361US2024150469A1Anti-b7-h1 antibodies for treating tumorsMEDIMMUNE LTD·Filed 2023·Application pending·0 cites
- 1458US2016271133A1Methods of Treating Multiple Myeloma and Resistant CancersPROLEXYS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1553US2016015710A1Methods of Treating Multiple Myeloma and Resistant CancersPROLEXYS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1644US2022241263A1Pd-1 axis binding antagonist to treat cancer with genetic mutations in specific genesARES TRADING SA·Filed 2020·Application pending·0 cites
- 1744US2009170834A1Fused Pyrimidones and Thiopyrimidones, and Uses ThereofPROLEXYS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1831US2016031990A1Antagonists of pdl-1 and pd-1 for the treatment of hpv-negative cancersMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
- 1929US2016060344A1Combination therapy for pd-l1 negative tumorsNARWAL RAJESH·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul Robbins files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →